Lncrna CASC11 aggravates diabetic nephropathy via targeting FoxO1

BACKGROUND: To explore the biological effects of CASC11 on aggravating diabetic nephropathy (DN) by regulating FoxO1 (forkhead transcription factor O1). METHODS: Serum levels of CASC11 and FoxO1 in DN patients were detected. The possibility of CASC11 in predicting the onset of DN was analyzed by dep...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yun, Shi, Shuhan, Lin, Changda, Che, Lishuang, Li, Yuangen, Zeng, Quanzuan, Lin, Weiyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Medical Biochemists of Serbia, Belgrade 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542706/
https://www.ncbi.nlm.nih.gov/pubmed/37790209
http://dx.doi.org/10.5937/jomb0-42345
Descripción
Sumario:BACKGROUND: To explore the biological effects of CASC11 on aggravating diabetic nephropathy (DN) by regulating FoxO1 (forkhead transcription factor O1). METHODS: Serum levels of CASC11 and FoxO1 in DN patients were detected. The possibility of CASC11 in predicting the onset of DN was analyzed by depicting ROC curves. Correlation between CASC11 and FoxO1 was evaluated by Pearson correlation test. After intervening CASC11 and FoxO1 levels, we found that changes in proliferative and migratory abilities in high glucose (HG)induced kidney mesangial cells were determined respectively. Protein levels of TGF-β1 and Smads regulated by both CASC11 and FoxO1 were examined by Western blot.

Ejemplares similares